In this systematic review of the literature, we summarized publications on onabotulinumtoxinA injections in adult patients treated for upper- or lower-limb spasticity. Our goal was to review the ...

Upper limb spasticity is a painful condition caused by extremely tight muscles that can't be controlled. It's often a side effect of stroke, neurological disease or brain injury, but a new type of ...

The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...

What Is Upper Limb Spasticity? Upper limb spasticity is a condition that affects the way you move your arms. It makes your muscles stiff and flexed. Sometimes, your arms will twitch or move in a way ...

The Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA; Allergan) for the treatment of upper limb spasticity in pediatric patients 2-17 years of age. The approval was based on ...

Many stroke patients suffer from spasticity of the arm that cause pain and impaired sensorimotor function. But there are ways of identifying such patients ahead of time so that they can obtain the ...

FDA approved an expanded Botox label, which now includes eight new muscles to treat adults with upper limb spasticity. On July 29, 2021, Allergan, an AbbVie company, announced that FDA approved a ...

A advancement in the diagnosis of upper limb (UL) spasticity is on the horizon, moving beyond traditional reliance on clinicians' tactile assessments. Researchers affiliated with UNIST have developed ...

- Revance now expects to report topline results from JUNIPER trial in early 2021 - NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on ...

Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...